Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: Preventing dementia by preventing stroke: The Berlin Manifesto.
暂无分享,去创建一个
S. Black | L. Friberg | M. Endres | W. Hacke | C. Iadecola | L. Kuller | Z. Khachaturian | N. Nishimura | K. Einhäupl | C. Brayne | V. Hachinski | B. Norrving | M. Dichgans | D. Ganten | Y. Joanette | B. Stephan | L. Østergaard | C. Schaffer | Y. Iturria-Medina | S. Greenberg | B. Rowe | J. Wardlaw | B. Zlokovic | S. Whitehead | S. Alladi | Melanie D. Sweeney | K. Einhäupl | S. Black | Y. Iturria-medina
[1] B. Norrving,et al. Helsingborg Declaration 2006 on European Stroke Strategies , 2006, Cerebrovascular Diseases.
[2] R. Righart,et al. Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts , 2015, Neurology.
[3] V. Hachinski,et al. The reciprocal risks of stroke and cognitive impairment in an elderly population , 2006, Alzheimer's & Dementia.
[4] J. Wardlaw,et al. Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study , 2017, Alzheimer's & Dementia.
[5] Zhen Zhao,et al. Establishment and Dysfunction of the Blood-Brain Barrier , 2015, Cell.
[6] J. Wardlaw,et al. Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions , 2015, International journal of stroke : official journal of the International Stroke Society.
[7] K. Rhodes,et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease , 2016, Nature.
[8] G. Wang,et al. Dietary salt promotes neurovascular and cognitive dysfunction through a gut-initiated TH17 response , 2018, Nature Neuroscience.
[9] C. Iadecola,et al. Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. , 2016, The Journal of clinical investigation.
[10] George A. Carlson,et al. Alterations in Cerebral Blood Flow and Glucose Utilization in Mice Overexpressing the Amyloid Precursor Protein , 2002, Neurobiology of Disease.
[11] J. de Pina-Cabral. World , 2005, Science.
[12] Denise C. Park,et al. Risk factors for β-amyloid deposition in healthy aging: vascular and genetic effects. , 2013, JAMA neurology.
[13] W. Hacke,et al. Implementing the proclamation of stroke and potentially preventable dementias , 2018, Journal of clinical hypertension.
[14] D. Llewellyn,et al. Stroke and dementia risk: A systematic review and meta-analysis , 2018, Alzheimer's & Dementia.
[15] A. Levey,et al. Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically , 2008, BMC Neuroscience.
[16] M. Rosenqvist,et al. Less dementia with oral anticoagulation in atrial fibrillation , 2018, European heart journal.
[17] C. DeCarli,et al. Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging , 2018, JAMA neurology.
[18] Ivy Shiue,et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2016, The Lancet Neurology.
[19] Lei Yu,et al. Person‐specific contribution of neuropathologies to cognitive loss in old age , 2018, Annals of neurology.
[20] S. Yusuf,et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.
[21] V. Hachinski,et al. Progressive Increase in Infarct Size, Neuroinflammation, and Cognitive Deficits in the Presence of High Levels of Amyloid , 2007, Stroke.
[22] C. Iadecola,et al. Increased Susceptibility to Ischemic Brain Damage in Transgenic Mice Overexpressing the Amyloid Precursor Protein , 1997, The Journal of Neuroscience.
[23] L. Donini,et al. Secular Trends in Dementia Prevalence and Incidence Worldwide: A Systematic Review. , 2018, Journal of Alzheimer's disease : JAD.
[24] V. Hachinski,et al. Interaction Between a Rat Model of Cerebral Ischemia and &bgr;-Amyloid Toxicity: Inflammatory Responses , 2005, Stroke.
[25] Thomas Wisniewski,et al. Clearance systems in the brain—implications for Alzheimer disease , 2015, Nature Reviews Neurology.
[26] T. Bak,et al. Bilingualism delays age at onset of dementia, independent of education and immigration status , 2013, Neurology.
[27] C. Iadecola,et al. Cyclooxygenase 1–Derived Prostaglandin E2 and EP1 Receptors Are Required for the Cerebrovascular Dysfunction Induced by Angiotensin II , 2010, Hypertension.
[28] Joanna Wardlaw,et al. Action Plan for Stroke in Europe 2018–2030 , 2018, European stroke journal.
[29] C. Iadecola,et al. Angiotensin II Impairs Neurovascular Coupling in Neocortex Through NADPH Oxidase–Derived Radicals , 2004, Circulation research.
[30] Andrew Gibson,et al. Impaired behavioural flexibility related to white matter microgliosis in the TgAPP21 rat model of Alzheimer disease , 2019, Brain, Behavior, and Immunity.
[31] D. Stuss,et al. Subcortical hyperintensity volumetrics in Alzheimer’s disease and normal elderly in the Sunnybrook Dementia Study: correlations with atrophy, executive function, mental processing speed, and verbal memory , 2014, Alzheimer's Research & Therapy.
[32] Quanzheng Li,et al. Neurogenetic contributions to amyloid beta and tau spreading in the human cortex , 2018, Nature Medicine.
[33] Webb Ajs.,et al. Action Plan for Stroke in Europe , 2018 .
[34] Keith A. Johnson,et al. Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex , 2017, JAMA neurology.
[35] J. Bond,et al. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II , 2013, The Lancet.
[36] B. Zlokovic,et al. Hypertension Induces Brain &bgr;-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature , 2012, Hypertension.
[37] Thorbjørn S. Engedal,et al. Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[38] V. Hachinski. Stroke and Potentially Preventable Dementias Proclamation: Updated World Stroke Day Proclamation. , 2015, Stroke.
[39] David A. Bennett,et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.
[40] Andrew D. Johnson,et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.
[41] Andrei G. Vlassenko,et al. Loss of Brain Aerobic Glycolysis in Normal Human Aging. , 2017, Cell metabolism.
[42] C. Iadecola,et al. Cerebrovascular Nitrosative Stress Mediates Neurovascular and Endothelial Dysfunction Induced by Angiotensin II , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[43] Ping Zhou,et al. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein , 2008, Proceedings of the National Academy of Sciences.
[44] A. Thiel,et al. Neuroimaging in vascular cognitive impairment: a state-of-the-art review , 2016, BMC Medicine.
[45] Myriam Peyrounette,et al. Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer’s disease mouse models , 2018, Nature Neuroscience.
[46] Quincy M. Samus,et al. Dementia prevention, intervention, and care , 2017, The Lancet.
[47] Z. Khachaturian. The role of calcium regulation in brain aging: reexamination of a hypothesis , 1989, Aging.
[48] Kim Mouridsen,et al. Capillary Dysfunction: Its Detection and Causative Role in Dementias and Stroke , 2015, Current Neurology and Neuroscience Reports.
[49] J. Pierce,et al. Innate immunity receptor CD36 promotes cerebral amyloid angiopathy , 2013, Proceedings of the National Academy of Sciences.
[50] Andrew D. Johnson,et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.
[51] Keith A. Johnson,et al. Interactive Associations of Vascular Risk and &bgr;-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study , 2018, JAMA neurology.
[52] C. Brayne,et al. A commentary on studies presenting projections of the future prevalence of dementia , 2013, BMC Public Health.
[53] D. Stuss,et al. Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease , 2017, Alzheimer's & Dementia.
[54] V. Hachinski,et al. Multimodal Imaging of White Matter Inflammation in a Rat Model of Striatal Ischemic Stroke (P2.226) , 2018 .
[55] Alan J. Thomas,et al. TDP‐43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing , 2017, Brain pathology.
[56] Dan J Stein,et al. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.
[57] Norbert Schuff,et al. Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis , 2016, Nature Communications.
[58] C. Naus,et al. Comorbid Rat Model of Ischemia and β‐Amyloid Toxicity: Striatal and Cortical Degeneration , 2015, Brain pathology.
[59] V. Hachinski,et al. Interaction Between a Rat Model of Cerebral Ischemia and &bgr;-Amyloid Toxicity: II. Effects of Triflusal , 2005, Stroke.
[60] V. Hachinski,et al. Effects of pyrrolidine dithiocarbamate on beta-amyloid (25–35)-induced inflammatory responses and memory deficits in the rat , 2006, Neurobiology of Disease.
[61] C. Iadecola,et al. The cerebrovascular dysfunction induced by slow pressor doses of angiotensin II precedes the development of hypertension. , 2011, American journal of physiology. Heart and circulatory physiology.
[62] V. Hachinski. Dementia: Paradigm shifting into high gear , 2019, Alzheimer's & Dementia.
[63] Eric E. Smith,et al. Vascular dysfunction—The disregarded partner of Alzheimer's disease , 2019, Alzheimer's & Dementia.
[64] C. Iadecola. The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease , 2017, Neuron.
[65] Ken Arai,et al. Pathophysiologic Cascades in Ischemic Stroke , 2012, International journal of stroke : official journal of the International Stroke Society.
[66] B. Zlokovic,et al. Blood-Brain Barrier: From Physiology to Disease and Back. , 2019, Physiological reviews.
[67] Suvarna Alladi,et al. World dementia , 2018, Neurology.
[68] Lars Bäckman,et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.
[69] L. Robinson,et al. A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II , 2016, Nature Communications.
[70] U. Yoon,et al. Cortical thinning in subcortical vascular dementia with negative 11C-PiB PET. , 2012, Journal of Alzheimer's disease : JAD.
[71] S. Black,et al. Global hemispheric CT hypoperfusion may differentiate headache with associated neurological deficits and lymphocytosis from acute stroke. , 2008, Stroke.
[72] V. Hachinski,et al. Behavioural inflexibility in a comorbid rat model of striatal ischemic injury and mutant hAPP overexpression , 2017, Behavioural Brain Research.
[73] Henrik Zetterberg,et al. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity , 2017, Nature Communications.
[74] Alan C. Evans,et al. Multifactorial causal model of brain (dis)organization and therapeutic intervention: Application to Alzheimer’s disease , 2017, NeuroImage.
[75] Arthur W. Toga,et al. Brain imaging of neurovascular dysfunction in Alzheimer’s disease , 2016, Acta Neuropathologica.
[76] C. Iadecola,et al. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. , 2002, American journal of physiology. Heart and circulatory physiology.
[77] C. Iadecola,et al. Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[78] Keith A. Johnson,et al. Vascular Risk and β‐Amyloid Are Synergistically Associated with Cortical Tau , 2019, Annals of neurology.
[79] Arthur W. Toga,et al. Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.
[80] C. Iadecola,et al. Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex. , 2003, American journal of physiology. Heart and circulatory physiology.
[81] Piero Antuono,et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors , 2008, The Lancet Neurology.
[82] C. Iadecola,et al. Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[83] Z. Khachaturian. Calcium Hypothesis of Alzheimer's Disease and Brain Aging a , 1994, Annals of the New York Academy of Sciences.
[84] S. Whitehead,et al. Differential Anatomical Expression of Ganglioside GM1 Species Containing d18:1 or d20:1 Sphingosine Detected by MALDI Imaging Mass Spectrometry in Mature Rat Brain , 2015, Front. Neuroanat..
[85] A. Fagan,et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction , 2018, Nature Medicine.
[86] D. Na,et al. Increased Uptake of AV-1451 in a Subacute Infarction Lesion , 2018, Yonsei medical journal.
[87] Brian Levine,et al. Lesion Explorer: A comprehensive segmentation and parcellation package to obtain regional volumetrics for subcortical hyperintensities and intracranial tissue , 2011, NeuroImage.
[88] T. Bak,et al. Dementia in developing countries: Does education play the same role in India as in the West? , 2014, Dementia & neuropsychologia.
[89] V. Hachinski,et al. Declining Incidence of Stroke and Dementia: Coincidence or Prevention Opportunity? , 2015, JAMA neurology.
[90] D. Borchelt,et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.
[91] M. Kivipelto,et al. Dementia risk in renal dysfunction , 2017, Neurology.
[92] D. Cornfield,et al. A beta-peptides enhance vasoconstriction in cerebral circulation. , 2001, American journal of physiology. Heart and circulatory physiology.
[93] B. Zlokovic,et al. Alzheimer’s disease: A matter of blood–brain barrier dysfunction? , 2017, The Journal of experimental medicine.
[94] Leif Østergaard,et al. The roles of cerebral blood flow, capillary transit time heterogeneity, and oxygen tension in brain oxygenation and metabolism , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[95] C. Iadecola,et al. The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction , 2014, Nature Communications.
[96] Arthur W Toga,et al. The role of brain vasculature in neurodegenerative disorders , 2018, Nature Neuroscience.
[97] M. Dichgans,et al. Small vessel disease: mechanisms and clinical implications , 2019, The Lancet Neurology.
[98] W. Hacke,et al. Implementing the Proclamation of Stroke and Potentially Preventable Dementias , 2018, International journal of stroke : official journal of the International Stroke Society.
[99] I. McKeith,et al. Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study , 2009, PLoS medicine.
[100] J. Trojanowski,et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. , 2013, Brain : a journal of neurology.
[101] B. Lawlor,et al. Review: Blood pressure and dementia — a comprehensive review , 2009, Therapeutic advances in neurological disorders.
[102] Monique M. B. Breteler,et al. The changing prevalence and incidence of dementia over time — current evidence , 2017, Nature Reviews Neurology.
[103] M. Dichgans,et al. Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke , 2018, Neurology.
[104] Z. Khachaturian,et al. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis , 2017, Alzheimer's & Dementia.
[105] M. Dichgans,et al. Serum neurofilament light , 2018, Neurology.
[106] C. Iadecola. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia , 2010, Acta Neuropathologica.
[107] V. Hachinski,et al. APP21 transgenic rats develop age-dependent cognitive impairment and microglia accumulation within white matter tracts , 2018, Journal of Neuroinflammation.
[108] Alan C. Evans,et al. Multimodal imaging-based therapeutic fingerprints for optimizing personalized interventions: Application to neurodegeneration , 2018, NeuroImage.
[109] Rikesh M. Rajani,et al. Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats , 2018, Science Translational Medicine.
[110] C. Iadecola,et al. The Pathobiology of Vascular Dementia , 2013, Neuron.
[111] Arne Møller,et al. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease , 2017, Alzheimer's & Dementia.
[112] S. Pendlebury,et al. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis , 2009, The Lancet Neurology.
[113] Kim Mouridsen,et al. Increased cortical capillary transit time heterogeneity in Alzheimer's disease: a DSC-MRI perfusion study , 2017, Neurobiology of Aging.
[114] I. Aboderin,et al. Stroke management in Europe , 1996 .
[115] C. Iadecola. Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[116] Martin Dichgans,et al. Vascular cognitive impairment , 2017, Journal of the Neurological Sciences.
[117] D. Werring,et al. Outcome markers for clinical trials in cerebral amyloid angiopathy , 2001, The Lancet Neurology.
[118] P. Gorelick,et al. Risk Factors for Vascular Dementia and Alzheimer Disease , 2004, Stroke.
[119] A. Rahmim,et al. Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition , 2017, JAMA.
[120] V. Hachinski,et al. Concomitant vascular and neurodegenerative pathologies double the risk of dementia , 2018, Alzheimer's & Dementia.
[121] C. Iadecola,et al. Estrous Cycle–Dependent Neurovascular Dysfunction Induced by Angiotensin II in the Mouse Neocortex , 2009, Hypertension.
[122] Kim Mouridsen,et al. The role of the cerebral capillaries in acute ischemic stroke: the extended penumbra model , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[123] Ping Zhou,et al. Brain Perivascular Macrophages Initiate the Neurovascular Dysfunction of Alzheimer A&bgr; Peptides , 2017, Circulation research.
[124] V. Hachinski,et al. Population-based stroke and dementia incidence trends: Age and sex variations , 2017, Alzheimer's & Dementia.
[125] D. Cornfield,et al. Aβ-peptides enhance vasoconstriction in cerebral circulation , 2001 .
[126] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[127] C. DeCarli,et al. Impact of multiple pathologies on the threshold for clinically overt dementia , 2017, Acta Neuropathologica.
[128] Madelaine Daianu,et al. Pericyte degeneration causes white matter dysfunction in the mouse central nervous system , 2018, Nature Medicine.
[129] V. Hachinski,et al. Characterization of Behaviour and Remote Degeneration Following Thalamic Stroke in the Rat , 2015, International journal of molecular sciences.
[130] Henning U Voss,et al. Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function , 2018, Nature Communications.